Gut & Microbiome

1. Gut & Microbiomewell supported · human dataAdded 19 August 2026

   Gut microbiome therapies modestly lower blood sugar in type 2 diabetes

   Across 54 randomised trials in 3390 people with type 2 diabetes, gut microbiome-targeted therapies such as probiotics modestly improved blood sugar control, lowering HbA1c by 0.28% and fasting glucose by 7.97 mg/dL, and reduced inflammatory markers.

   ⚠What it shows: Modest but consistent: results pooled from 54 trials in 3390 people with type 2 diabetes mostly point the same way, though the trials disagreed with each other and few followed people for long, so lasting benefit is unproven.Meta-analysis · J Clin Endocrinol Metab

   Full breakdown →Insulin sensitivity explained →Metabolic Fitness Index →Glucose Parameters, Inflammation Markers, and Gut Microbiota Changes of Gut Microbiome-Targeted Therapies in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Endocrinol Metab 2025
2. Gut & Microbiomewell supported · human dataAdded 16 August 2026

   Fibre boosts specific gut bacteria, not overall diversity

   Dietary fibre interventions raised the abundance of Bifidobacterium and Lactobacillus species and faecal butyrate in healthy adults, but did not change overall microbial diversity, in results pooled from 64 randomised trials with 2099 participants. Fructans and galacto-oligosaccharides drove the largest bacterial gains.

   ⚠What it shows: Solid ground: results pooled from 64 trials in 2099 healthy adults, so the bacterial shifts look real. But the fibres and lab methods varied between studies, and higher counts of these bacteria are not yet proof of better health.Meta-analysis · Am J Clin Nutr

   Full breakdown →Gut microbiome explained →Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr 2018
3. Gut & Microbiomepreliminary · human dataAdded 15 August 2026

   Probiotics tighten the gut barrier, at least on lab markers

   Pooled data from 26 randomised trials in 1,891 people found probiotics improved laboratory markers of gut barrier function, including lower serum zonulin, endotoxin and LPS, and also reduced inflammatory markers such as CRP, TNF-α and IL-6 compared with control groups.

   ⚠What it shows: Encouraging but marker-deep: results pooled from 26 trials with 1,891 people showed changes in blood and laboratory measures of gut leakiness, not in symptoms people actually notice. The authors themselves say higher-quality trials are needed before drawing a definitive conclusion.Meta-analysis · Front Immunol

   Full breakdown →Probiotics explained →Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Front Immunol 2023
4. Gut & Microbiomepreliminary · human dataAdded 14 August 2026

   Gut bacteria supplements eased low mood and anxiety across 72 trials

   Probiotics, prebiotics and synbiotics each modestly reduced depression and anxiety scores compared with placebo across 72 randomised trials, and probiotics also improved sleep quality. Effects varied by population, intervention duration and probiotic type.

   ⚠What it shows: Encouraging but wobbly: results pooled from 72 trials showed modest benefits, yet the studies disagreed with each other a great deal and many were of limited quality, so the true effect may be smaller than it looks. The authors themselves call for larger, better trials with longer follow-up.Meta-analysis · BMC Psychiatry

   Full breakdown →Probiotics explained →Sleep Calculator →The efficacy of probiotics, prebiotics, and synbiotics on anxiety, depression, and sleep: a systematic review and meta-analysis of randomized controlled trials. BMC Psychiatry 2025
5. Gut & Microbiomepreliminary · human dataAdded 12 August 2026

   Probiotics gave healthy workers a small mood lift, and cortisol fell too

   Probiotic supplements had a modest but statistically significant effect on symptoms of depression, anxiety and stress in healthy working adults across 12 randomised trials of 3,350 people, and were linked to lower cortisol. A marker of systemic inflammation did not change.

   ⚠What it shows: Promising but not settled: results pooled from 12 trials in 3,350 healthy employed adults found only a modest effect. The trials used different strains, doses and durations, so nobody yet knows which probiotics actually help.Meta-analysis · BMC Psychol

   Full breakdown →Cortisol explained →Probiotic intake and mental health in healthy working adults: a systematic review and meta-analysis of randomized controlled trials. BMC Psychol 2026
6. Gut & Microbiomewell supported · human dataAdded 6 August 2026

   Probiotics shifted PCOS blood sugar, not the scales

   Pooling 8 randomised trials in women with polycystic ovary syndrome, probiotic or synbiotic supplements produced small reductions in fasting blood sugar (-2.52 mg/dl), insulin (-2.27 uIU/mL), HOMA-IR (-0.69), C-reactive protein and total testosterone (-0.12 ng/mL). Weight and body mass index did not change significantly.

   ⚠What it shows: Meta-analysis of only 8 RCTs (nine treatment arms) in women with polycystic ovary syndrome, searched to September 2018. The individual trials were small and short, effect sizes are modest, strains and doses varied between studies, and the findings do not transfer to women without PCOS.Meta-analysis · Eur J Clin Nutr

   Full breakdown →Insulin sensitivity explained →Metabolic Fitness Index →Effect of probiotics and synbiotics on selected anthropometric and biochemical measures in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Clin Nutr 2020
7. Gut & Microbiomepreliminary · human dataAdded 30 July 2026

   Bacteria grown from your own gut nudged metabolic markers

   In a 50-person pilot trial in people with metabolic syndrome, a 20-day course of "autoprobiotics", bacteria grown from each patient's own gut Enterococcus strains, reduced obesity measures, lowered glucose and HbA1c and left lower HbA1c and triglycerides than the nutritional mix alone by day 28, alongside larger shifts in gut bacteria.

   ⚠What it shows: A single 20-day pilot RCT in 50 adults aged 42-63 with metabolic syndrome (26 treated, 24 control) at one Russian centre, with short follow-up to day 28 and many microbiome outcomes reported, and the personalised strains are not an off-the-shelf product.RCT · Nutrients

   Full breakdown →Metabolic syndrome explained →Metabolic Fitness Index →Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial. Nutrients 2026
8. Gut & Microbiomepreliminary · human dataAdded 29 July 2026

   Probiotic brain effects lingered weeks after stopping

   In a small trial of 32 healthy older adults, some brain effects of a six-week probiotic, differences in resting-state functional connectivity and in anxiety and depression scores, were still detectable 4-6 weeks after intake stopped, while other changes had faded. The persistent differences appeared between the two probiotic formulations rather than against baseline.

   ⚠What it shows: Exploratory follow-up of one randomised, blinded, placebo-controlled trial in 32 self-reported healthy older adults (mean age 68.0 years); only 8 to 12 participants per group were analysed out of about 30 randomised each, brain function was an exploratory outcome of the parent study, and psychological measures were exploratory throughout.Study · Commun Med (Lond)

   Full breakdown →Probiotics guide →Probiotic effects on brain health are both transient and sustained for several weeks after discontinuation: a randomised controlled trial. Commun Med (Lond) 2026
9. Gut & Microbiomepreliminary · human dataAdded 27 July 2026

   Gut bacteria before a diet predicted who stayed well

   In a microbiome analysis of adults with mild-to-moderate Crohn's disease on the Crohn's disease exclusion diet, those who sustained remission at both weeks 12 and 24 had a distinct gut profile at baseline, lower alpha diversity and more Alistipes and Faecalibacterium, while Haemophilus and Prevotella were negatively linked to remission.

   ⚠What it shows: Secondary microbiome analysis of two randomised trials, one in adults and one in children, with no sample size given for the remission comparison; associations between baseline bacteria and later remission are correlational and need prospective validation.Study · Crohns Colitis 360

   Full breakdown →Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls. Crohns Colitis 360 2026
10. Gut & Microbiomepreliminary · human dataAdded 26 July 2026

    Probiotics and depression: mostly null results

    Pooling 27 randomised trials, probiotics showed no significant effect on depressive symptoms over short (under 6 weeks) or medium (6-12 weeks) durations, with a significant benefit appearing only in a long-duration subgroup of just 2 studies. Prebiotics and postbiotics showed no clear effects.

    ⚠What it shows: Systematic review and meta-analysis of 27 RCTs published 2016-2024, but the only significant signal rests on 2 long-duration trials; substantial heterogeneity across studies and overall certainty rated moderate for inconsistency.Review · Nutr Neurosci

    Full breakdown →Probiotics guide →Efficacy of prebiotics, probiotics, and postbiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci 2026

Back to the full archive · this week’s studies